We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
SCCM
151
Schafer Cullen Capital Management
New York
$134M -$7.53M -239,267 -5%
YCMGA
152
York Capital Management Global Advisors
New York
$133M +$137M +4,347,650 New
Citadel Advisors
153
Citadel Advisors
Florida
$133M +$111M +3,515,460 +423%
O
154
OrbiMed
New York
$133M +$12M +380,494 +10%
NRECA
155
National Rural Electric Cooperative Association
Virginia
$133M
IIM
156
Ivory Investment Management
New York
$128M +$132M +4,191,195 New
EVM
157
Eaton Vance Management
Massachusetts
$128M +$997K +31,684 +0.8%
SCM
158
Shapiro Capital Management
Georgia
$128M +$30.1M +955,508 +30%
PI
159
PGGM Investments
Netherlands
$128M -$5.16M -163,960 -4%
M&T Bank
160
M&T Bank
New York
$127M -$46.5K -1,477 -0%
DekaBank Deutsche Girozentrale
161
DekaBank Deutsche Girozentrale
Germany
$126M +$4.08M +129,779 +3%
MPI
162
Mairs & Power Inc
Minnesota
$126M +$27.6M +878,419 +27%
SB
163
Suntrust Banks
Georgia
$125M +$1.23M +39,157 +1%
EAM
164
Eagle Asset Management
Florida
$124M +$1.96M +62,396 +2%
N
165
Natixis
France
$123M +$7.41M +235,458 +6%
Federated Hermes
166
Federated Hermes
Pennsylvania
$121M +$8.68M +275,971 +8%
BG
167
Bahl & Gaynor
Ohio
$121M -$20.2M -640,579 -14%
Swedbank
168
Swedbank
Sweden
$119M +$1.53M +48,494 +1%
First Manhattan
169
First Manhattan
New York
$118M +$66.8M +2,123,197 +122%
NC
170
Nicholas Company
Wisconsin
$116M +$21M +667,951 +22%
MIP
171
Mondrian Investment Partners
United Kingdom
$112M -$606K -19,254 -0.5%
Susquehanna International Group
172
Susquehanna International Group
Pennsylvania
$111M +$61.8M +1,963,109 +119%
VFA
173
Virtus Fund Advisers
Connecticut
$111M -$7.07M -224,621 -6%
Two Sigma Investments
174
Two Sigma Investments
New York
$110M +$11.5M +364,359 +11%
EIP
175
Epoch Investment Partners
New York
$109M -$1.53M -48,527 -1%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.